Impact of Cyp1a2 or Ahr gene knockout in mice: implications for biomonitoring studies

Glenn Talaska1, David Ginsburg, Kathy LaDow

  • 1The Department of Environmental Health, The University of Cincinnati School of Medicine, 3223 Eden Ave, Cincinnati, OH 45267-0056, USA. Glenn.Talaska@UC.edu

Toxicology Letters
|November 1, 2005
PubMed
Abstract

Insights

Ablating specific genes in mice altered genetic damage from chemical exposure in a tissue-specific manner. Gene knockouts significantly reduced benzo(a)pyrene DNA adducts in skin, but not other compounds or tissues.

Area of Science:

  • Toxicology
  • Genetics
  • Biochemistry

Background:

  • Polymorphisms in Phase I enzymes can influence genetic damage.
  • Previous studies on enzyme polymorphisms and genetic damage have shown inconsistent results.

Purpose of the Study:

  • To investigate the impact of ablating specific genes on genetic damage under low-dose exposure conditions.
  • To determine the role of Cyp1a2 and Ahr receptor in DNA adduct formation.

Main Methods:

  • Generated Cyp1a2 and Ahr receptor knockout (KO) mice.
  • Treated mice with 4-aminobiphenyl (4ABP), benzo(a)pyrene (BaP), or dibenzo(c,g)carbazole (DBC).
  • Isolated and labeled DNA from liver, skin, and urinary bladder for adduct analysis.

Main Results:

  • Cyp1a2 KO mice showed no difference in 4ABP DNA adducts in bladder or liver.
  • Cyp1a2 KO reduced skin BaP adducts by 50%; AHR KO reduced skin BaP adducts by 90%.
  • Neither knockout affected DBC-DNA adduct levels in any tissue.

Conclusions:

  • Ablation of metabolizing enzymes has compound- and tissue-specific effects.
  • Variations in single CYP enzymes may have minimal impact in humans at low doses.
  • Variations in the ability to induce CYPs might have a greater impact on human health.